Concise review: Production of cultured red blood cells from stem cells

Stem Cells Translational Medicine

Volumn 1, Issue 12, 2012, Pages 927-933

  Bouhassira, Eric E ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Adult stem cells; Embryonic stem cells; Erythropoiesis; Stem progenitor cell

Indexed keywords

CD34 ANTIGEN; FIBROBLAST GROWTH FACTOR 2; HEMOGLOBIN A; HEMOGLOBIN F; PROTEIN BCL 2; PROTEIN BCL XL; RAF PROTEIN; SOMATOMEDIN B; STEM CELL FACTOR; TELOMERASE REVERSE TRANSCRIPTASE; THROMBOPOIETIN; TRANSCRIPTION FACTOR GATA 1; TRANSCRIPTION FACTOR PU 1;

CELL CULTURE; EMBRYONIC STEM CELL; ERYTHROCYTE; ERYTHROPOIESIS; HUMAN; LIQUID CULTURE; NONHUMAN; PLURIPOTENT STEM CELL; REVIEW; SCALE UP; SICKLE CELL ANEMIA; STEM CELL; BLOOD BANK; BLOOD TRANSFUSION; CELL LINE; CYTOLOGY; HEMATOPOIETIC STEM CELL; METHODOLOGY;

BLOOD BANKS; BLOOD TRANSFUSION; CELL LINE, TRANSFORMED; CELLS, CULTURED; ERYTHROCYTES; HEMATOPOIETIC STEM CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS;

MLCS; MLOWN;

EID: 84872900396     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2012-0097     Document Type: Review

References (86)

1. Whitaker BI, Schlumpf K, Schulman J et al. The 2009 National Blood Collection and Utilization Survey Report. Washington, D.C.: U.S. Department of Health and Human Services, Office of the Assistant Secretary for Health, 2011.
2. Adams RJ, Brambilla D. Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. N Engl J Med 2005;353: 2769-2778.
3. Adams RJ, McKie VC, Hsu L et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 1998;339:5-11.
4. Westhoff CM, Reid M. Transfusion medicine: Human blood group antigens and antibodies. In: Hoffman R, EB, Shattil S, Furie B et al., eds. Hematology Basic Principles and Practice. 5th ed. 2010.
5. Hess JR, Thomas MJ. Blood use in war and disaster: Lessons from the past century. Transfusion 2003;43:1622-1633.
6. Zimrin AB, Hess JR. Planning for pandemic influenza: Effect of a pandemic on the supply and demand for blood products in the United States. Transfusion 2007;47:1071-1079.
7. Ali A, Auvinen MK, Rautonen J. The aging population poses a global challenge for blood services. Transfusion 2010;50:584-588.
8. Orkin SH, Zon LI. Hematopoiesis: An evolving paradigm for stem cell biology. Cell 2008; 132:631-644.
9. Hattangadi SM, Wong P, Zhang L et al. From stem cell to red cell: Regulation of erythropoiesis at multiple levels by multiple proteins, RNAs, and chromatin modifications. Blood 2011;118:6258-6268.
10. Giarratana MC, Rouard H, Dumont A et al. Proof of principle for transfusion of in vitrogenerated red blood cells. Blood 2011;118: 5071-5079.
11. Fujimi A, Matsunaga T, Kobune M et al. Ex vivo large-scale generation of human red blood cells from cord blood CD34 cells by coculturing with macrophages. Int J Hematol 2008;87:339-350.
12. Leberbauer C, Boulme F, Unfried G et al. Different steroids co-regulate long-term expansion versus terminal differentiation in primary human erythroid progenitors. Blood 2005;105:85-94.
13. Giarratana MC, Kobari L, Lapillonne H et al. Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells. Nat Biotechnol 2005;23:69-74.
14. Timmins NE, Athanasas S, Gunther M et al. Ultra-high-yield manufacture of red blood cells from hematopoietic stem cells. Tissue Eng Part C Methods 2011;17:1131-1137.
15. Duncan EL, Wadhwa R, Kaul SC. Senescence and immortalization of human cells. Biogerontology 2000;1:103-121.
16. Hahn WC. Immortalization and transformation of human cells. Mol Cells 2002;13:351-361.
17. Lundberg AS, Hahn WC, Gupta P et al. Genes involved in senescence and immortalization. Curr Opin Cell Biol 2000;12:705-709.
18. Migliaccio AR, Rana RA, Vannucchi AM et al. Role of GATA-1 in normal and neoplastic hemopoiesis. Ann NY Acad Sci 2005;1044:142-158.
19. Rekhtman N, Radparvar F, Evans T et al. Direct interaction of hematopoietic transcription factors PU.1 and GATA-1: Functional antagonism in erythroid cells. Genes Dev 1999; 13:1398-1411.
20. Zhang P, Behre G, Pan J et al. Negative cross-talk between hematopoietic regulators: GATA proteins repress PU.1. Proc Natl Acad Sci USA 1999;96:8705-8710.
21. Back J, Dierich A, Bronn C et al. PU.1 determines the self-renewal capacity of erythroid progenitor cells. Blood 2004;103:3615-3623.
22. Wontakal SN, Guo X, Will B et al. A large gene network in immature erythroid cells is controlled by the myeloid and B cell transcriptional regulator PU.1. PLoS Genet 2011;7: e1001392.
23. Tian C, Gregoli P, Bondurant M. The function of the bcl-x promoter in erythroid progenitor cells. Blood 2003;101:2235-2242.
24. Quang CT, Pironin M, von Lindern M et al. Spi-1 and mutant p53 regulate different aspects of the proliferation and differentiation control of primary erythroid progenitors. Oncogene 1995;11:1229-1239.
25. Kosmider O, Denis N, Lacout C et al. Kitactivating mutations cooperate with Spi-1/ PU.1 overexpression to promote tumorigenic progression during erythroleukemia in mice. Cancer Cell 2005;8:467-478.
26. Coppola JA, Cole MD. Constitutive c-myc oncogene expression blocks mouse erythroleukaemia cell differentiation but not commitment. Nature 1986;320:760-763.
27. Cory S, Maekawa T, McNeall J et al. Murine erythroid cell lines derived with c-myc retroviruses respond to leukemia-inhibitory factor, erythropoietin, and interleukin 3. Cell Growth Differ 1991;2:165-172.
28. Lachman HM, Cheng GH, Skoultchi AI. Transfection of mouse erythroleukemia cells with myc sequences changes the rate of induced commitment to differentiate. Proc Natl Acad Sci USA 1986;83:6480-6484.
29. Lachman HM, Skoultchi AI. Expression of c-myc changes during differentiation of mouse erythroleukaemia cells. Nature 1984;310:592-594.
30. Prochownik EV, Kukowska J. Deregulated expression of c-myc by murine erythroleukaemia cells prevents differentiation. Nature 1986;322:848-850.
31. Skoda RC, Tsai SF, Orkin SH et al. Expression of c-MYC under the control of GATA-1 regulatory sequences causes erythroleukemia in transgenic mice. J Exp Med 1995;181:1603-1613.
32. Ghysdael J, Tran Quang C, Deiner EM et al. Erythroid cell development and leukemic transformation: Interplay between signal transduction, cell cycle control and oncogenes. Pathol Biol (Paris) 2000;48:211.
33. Schuetze S, Stenberg PE, Kabat D. The Ets-related transcription factor PU.1 immortalizes erythroblasts. Mol Cell Biol 1993;13:5670-5678.
34. Weiss MJ, Yu C, Orkin SH. Erythroid-cellspecific properties of transcription factor GATA-1 revealed by phenotypic rescue of a gene-targeted cell line. Mol Cell Biol 1997;17: 1642-1651.
35. Metz T. Oncogenes and erythroid differentiation. Semin Cancer Biol 1994;5:125-135.
36. Metz T, Harris AW, Adams JM. Absence of p53 allows direct immortalization of hematopoietic cells by the myc and raf oncogenes. Cell 1995;82:29-36.
37. Nakamura Y, Hiroyama T, Miharada K et al. Red blood cell production from immortalized progenitor cell line. Int J Hematol 2011;93: 5-9.
38. Hiroyama T, Miharada K, Sudo K et al. Establishment of mouse embryonic stem cellderived erythroid progenitor cell lines able to produce functional red blood cells. PLoS One 2008;3:e1544.
39. Okita K, Yamanaka S. Induced pluripotent stem cells: Opportunities and challenges. Philos Trans R Soc Lond B Biol Sci 2011;366: 2198-2207.
40. Kaufman DS, Hanson ET, Lewis RL et al. Hematopoietic colony-forming cells derived from human embryonic stem cells. Proc Natl Acad Sci USA 2001;98:10716-10721.
41. Vodyanik MA, Bork JA, Thomson JA et al. Human embryonic stem cell-derived CD34 cells: Efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential. Blood 2005;105:617-626.
42. Vodyanik MA, Thomson JA, Slukvin II. Leukosialin (CD43) defines hematopoietic progenitors in human embryonic stem cell differentiation cultures. Blood 2006;108:2095-2105.
43. Qiu C, Hanson E, Olivier E et al. Differentiation of human embryonic stem cells into hematopoietic cells by coculture with human fetal liver cells recapitulates the globin switch that occurs early in development. Exp Hematol 2005;33:1450-1458.
44. Chadwick K, Wang L, Li L et al. Cytokines and BMP-4 promote hematopoietic differentiation of human embryonic stem cells. Blood 2003;102:906-915.
45. Zambidis ET, Peault B, Park TS et al. Hematopoietic differentiation of human embryonic stem cells progresses through sequential hematoendothelial, primitive, and definitive stages resembling human yolk sac development. Blood 2005;106:860-870.
46. Chang KH, Nelson AM, Cao H et al. Definitive-like erythroid cells derived from human embryonic stem cells coexpress high levels of embryonic and fetal globins with little or no adult globin. Blood 2006;108:1515-1523.
47. Mazurier C, Douay L, Lapillonne H. Red blood cells from induced pluripotent stem cells: Hurdles and developments. Curr Opin Hematol 2011;18:249-253.
48. Pearson HA. Life-span of the fetal red blood cell. J Pediatr 1967;70:166-171.
49. Bunn HF, Briehl RW. The interaction of 2,3-diphosphoglycerate with various human hemoglobins. J Clin Invest 1970;49:1088-1095.
50. Mohandas N, Gallagher PG. Red cell membrane: Past, present, and future. Blood 2008;112:3939-3948.
51. Maniatis T, Fritsch EF, Lauer J et al. The molecular genetics of human hemoglobins. Annu Rev Genet 1980;14:145-178.
52. Chen MJ, Li Y, De Obaldia ME et al. Erythroid/myeloid progenitors and hematopoietic stem cells originate from distinct populations of endothelial cells. Cell Stem Cell 2011; 9:541-552.
53. Forget BG. Molecular basis of hereditary persistence of fetal hemoglobin. Ann NY Acad Sci 1998;850:38-44.
54. Zipursky A. The erythrocytes of the newborn infant. Semin Hematol 1965;2:167-203.
55. Bhattacharya N. Placental umbilical cord whole blood transfusion: A safe and genuine blood substitute for patients of the under-resourced world at emergency. J Am Coll Surg 2005;200:557-563.
56. Bianchi M, Landini A, Giannatonio C et al. Allogeneic cord blood red cells for transfusion. Transfus Med Rev 2012;26:90-91, author reply 91-92.
57. Qiu C, Olivier EN, Velho M et al. Globin switches in yolk sac-like primitive and fetal-like definitive red blood cells produced from human embryonic stem cells. Blood 2008;111: 2400-2408.
58. Olivier EN, Qiu C, Velho M et al. Largescale production of embryonic red blood cells from human embryonic stem cells. Exp Hematol 2006;34:1635-1642.
59. Vodyanik MA, Slukvin, II. Hematoendothelial differentiation of human embryonic stem cells. Curr Protoc Cell Biol 2007;Chapter 23:Unit 23.6.
60. Chang CJ, Mitra K, Koya M et al. Production of embryonic and fetal-like red blood cells from human induced pluripotent stem cells. PLoS One 2011;6:e25761.
61. Garritsen HS, Brune T, Louwen F et al. Autologous red cells derived from cord blood: Collection, preparation, storage and quality controls with optimal additive storage medium (Sag-mannitol). Transfus Med 2003;13:303310.
62. Fibach E, Manor D, Oppenheim A et al. Proliferation and maturation of human erythroid progenitors in liquid culture. Blood 1989;73:100-103.
63. Freyssinier JM, Lecoq-Lafon C, Amsellem S et al. Purification, amplification and characterization of a population of human erythroid progenitors. Br J Haematol 1999;106:912-922.
64. Panzenböck B, Bartunek P, Mapara MY et al. Growth and differentiation of human stem cell factor/erythropoietin-dependent erythroid progenitor cells in vitro. Blood 1998; 92:3658-3668.
65. Douay L, Giarratana MC. Ex vivo generation of human red blood cells: A new advance in stem cell engineering. Methods Mol Biol 2009;482:127-140.
66. Neildez-Nguyen TM, Wajcman H, Marden MC et al. Human erythroid cells produced ex vivo at large scale differentiate into red blood cells in vivo. Nat Biotechnol 2002;20: 467-472.
67. Dolznig H, Kolbus A, Leberbauer C et al. Expansion and differentiation of immature mouse and human hematopoietic progenitors. Methods Mol Med 2005;105:323-344.
68. Carotta S, Pilat S, Mairhofer A et al. Directed differentiation and mass cultivation of pure erythroid progenitors from mouse embryonic stem cells. Blood 2004;104:1873-1880.
69. Migliaccio G, Masiello F, Tirelli V et al. Under HEMA conditions, self-replication of human erythroblasts is limited by autophagic death. Blood Cells Mol Dis 2011;47:182-197.
70. Ghinassi BTM, Chang K-H, Halverson G et al. Comparative blood group profiling of human erythroid cells (EBs) generated from adult blood (AB), cord blood (CB), human embryonic stem cells (hESC) and induced pluripotent stem cells (iPS). Blood (ASH Annual Meeting Abstracts) 2011;118:1027.
71. Migliaccio G, Sanchez M, Masiello F et al. Humanized culture medium for clinical expansion of human erythroblasts. Cell Transplantation 2010;19:453-469.
72. Migliaccio AR, Whitsett C, Migliaccio G. Erythroid cells in vitro: From developmental biology to blood transfusion products. Curr Opin Hematol 2009;16:259-268.
73. Migliaccio G, Di Pietro R, di Giacomo V et al. In vitro mass production of human erythroid cells from the blood of normal donors and of thalassemic patients. Blood Cells Mol Dis 2002; 28:169-180.
74. Migliaccio G, Migliaccio AR, Druzin ML et al. Long-term generation of colony-forming cells in liquid culture of CD34_cord blood cells in the presence of recombinant human stem cell factor. Blood 1992;79:2620-2627.
75. England SJ, McGrath KE, Frame JM et al. Immature erythroblasts with extensive ex vivo self-renewal capacity emerge from the early mammalian fetus. Blood 2011;117:2708-2717.
76. Olivier E, Qiu C, Bouhassira, EE. Novel, high-yield red blood cell production methods from cells derived from human embryonic stem, yolk sac, fetal liver, cord blood, and peripheral blood. STEM CELLS TRANSLATIONALMEDICINE 2012;1:604-614.
77. Sorrentino BP. Clinical strategies for expansion of haematopoietic stem cells. Nat Rev Immunol 2004;4:878-888.
78. Zhang CC, Kaba M, Iizuka S et al. Angiopoietinlike 5 and IGFBP2 stimulate ex vivo expansion of human cord blood hematopoietic stem cells as assayed by NOD/SCID transplantation. Blood 2008;111:3415-3423.
79. Zhang CC, Kaba M, Ge G et al. Angiopoietinlike proteins stimulate ex vivo expansion of hematopoietic stem cells. Nat Med 2006;12: 240-245.
80. Boitano AE, Wang J, Romeo R et al. Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells. Science 2010;329:1345-1348.
81. Miharada K, Hiroyama T, Sudo K et al. Efficient enucleation of erythroblasts differentiated in vitro from hematopoietic stem and progenitor cells. Nat Biotechnol 2006;24: 1255-1256.
82. Lu SJ, Feng Q, Park JS et al. Biologic properties and enucleation of red blood cells from human embryonic stem cells. Blood 2008;112: 4475-4484.
83. Timmins NE, Nielsen LK. Manufactured RBC: Rivers of blood, or an oasis in the desert? Biotechnol Adv 2011;29:661-666.
84. Timmins NE, Nielsen LK. Blood cell manufacture: Current methods and future challenges. Trends Biotechnol 2009;27:415-422.
85. Housler GJ, Miki T, Schmelzer E et al. Compartmental hollow fiber capillary membranebased bioreactor technology for in vitro studies on red blood cell lineage direction of hematopoietic stem cells. Tissue Eng Part C Methods 2012;18:133-142.
86. Peyrard T, Bardiaux L, Krause C et al. Banking of pluripotent adult stem cells as an unlimited source for red blood cell production: Potential applications for alloimmunized patients and rare blood challenges. Transfus Med Rev 2011;25:206-216.